Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Death; uncontactable; impaired general condition; fever; mottled on the legs; This is a spontaneous report from a contactable nurse downloaded from the regulatory authority-WEB (Regulatory authority numbers SE-MPA-2021-009261 and SE-MPA-1614601604152). An 83-year-old female patient received BNT162B2 (COMIRNATY, lot number EJ6797) intramuscular, in Feb2021, at 0.3 ml single, for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease, vascular dementia and asthma, all from an unknown date and unknown if ongoing. The patient had 24 unspecified concomitant medications. The patient was vaccinated and rapidly deteriorated two days later with impaired general condition, fever, was uncontactable and became mottled on the legs. The patient died three days after Comirnaty was given, on an unspecified date in Feb2021. Report assessed as serious (fatal) for death. The other events outcome was unknown. It was unknown if an autopsy was done. No follow-up attempts are possible. No further information expected.; Reported Cause(s) of Death: Death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166